| Title: | Associations between serum 25-hydroxyvitamin D and risk of new-onset peripheral neuropathy: a modifying effect of diabetes |
| Journal: | Precision Nutrition |
| Published: | 18 Mar 2024 |
| DOI: | https://doi.org/10.1097/pn9.0000000000000066 |
| URL: | http://dx.doi.org/10.1097/pn9.0000000000000066 |
Publication 10098
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
The longitudinal association between vitamin D status and risk of peripheral neuropathy is still undetermined. We aimed to assess the relation of serum 25-hydroxyvitamin D (25OHD) with new-onset peripheral neuropathy in participants with and without diabetes at baseline. A total of 386,715 participants from UK Biobank without peripheral neuropathy at baseline were included. Serum concentrations of 25OHD were measured using chemiluminescent immunoassay method. The primary outcome was new-onset peripheral neuropathy. Over a median follow-up duration of 12.0 years, 2742 (0.7%) participants developed new-onset peripheral neuropathy. Overall, serum 25OHD was inversely associated with the risk of new-onset peripheral neuropathy among participants with diabetes (per standard deviation [SD] increment, adjusted hazard ratio [HR]: 0.82, 95% confident interval [95% CI]: 0.76-0.89), but significantly attenuated among those without diabetes (per SD increment, adjusted HR: 0.93, 95% CI: 0.89-0.99; P for interaction between serum 25OHD and diabetes = 0.004). Accordingly, among participants with diabetes, compared with those serum 25OHD <25 nmol/L, a significantly lower risk of new-onset peripheral neuropathy was found in those with 25OHD 25-<50 nmol/L (adjusted HR: 0.65; 95% CI: 0.56-0.77), and ≥50 nmol/L (adjusted HR: 0.60; 95% CI: 0.50-0.72). Moreover, none of other covariates, including age, sex, body mass index, physical activity, diets, C-reactive protein, glucose, and use of anti-hypertensive drugs significantly modified the association between serum 25OHD and new-onset peripheral neuropathy in those with and without diabetes (all P for interactions >0.05). There was an inverse association between serum 25OHD and new-onset peripheral neuropathy in participants with diabetes. The inverse association was significantly attenuated among participants without diabetes.</p>
9 Authors
- Chun Zhou
- Xiaoqin Gan
- Ziliang Ye
- Panpan He
- Yanjun Zhang
- Sisi Yang
- Qimeng Wu
- Mengyi Liu
- Yuanyuan Zhang
1 Application
| Application ID | Title |
|---|---|
| 73201 | Identification of residual risks of non-infectious chronic diseases |
Enabling scientific discoveries that improve human health